Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

NCT04979975 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Genital Herpes

Interventions

OTHER: Placebo
BIOLOGICAL: UB-621 low-dose
BIOLOGICAL: UB-621 high-dose

Sponsor

UBP Greater China (Shanghai) Co., Ltd